Skip to content
DataLookout
Menu

MYEL-CD180NCT07895901

Characterization of CD180 Protein Expression in Myeloid Hematological Malignancies by Flow Cytometry

StatusRecruiting
PhaseNot specified
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

CD180 Expression in Normal and Pathological CD34+ Cells
Timeframe: During the 6-month data collection period, from January 21, 2026, to July 21, 2027.

Sites

1 site in 1 country

  • Laboratoire d'Hématologie Biologique - CHU de Strasbourg - FranceStrasbourg, France